Test Code LAB1231806 Alpha-Fetoprotein (AFP) L3% and Total, Hepatocellular Carcinoma Tumor Marker, Serum
Performing Laboratory
Mayo Clinic Laboratories in RochesterReporting Name
AFP-L3% and Total AFP, SSpecimen Type
SerumSpecimen Required
Collection Container/Tube:
Preferred: Serum Gel
Acceptable: Red Top
Submission Container/Tube: Plastic vial
Specimen Volume: 0.5 mL
Collection Instructions: Centrifuge and aliquot serum into a plastic vial.
Reject Due To
Gross hemolysis | Reject |
Gross lipemia | OK |
Gross icterus | OK |
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum | Frozen (preferred) | 180 days | |
Refrigerated | 5 days |
Specimen Minimum Volume
0.2 mL
Day(s) Performed
Monday through Friday
Specimen Retention Time
14 daysReport Available
1 to 4 daysReference Values
TOTAL ALPHA-FETOPROTEIN (AFP):
<4.7 ng/mL
AFP %L3:
<10%
Useful For
Distinguishing between hepatocellular carcinoma and chronic liver disease
Monitoring individuals with hepatic cirrhosis from any etiology for progression to hepatocellular carcinoma
Surveillance for development of hepatocellular carcinoma in individuals with a positive family history of hepatic cancer
Surveillance for development of hepatocellular carcinoma in individuals within specific ethnic and sex groups who do not have hepatic cirrhosis but have a confirmed diagnosis of chronic infection by hepatitis B acquired early in life, including:
-African men above the age of 20
-Asian men above the age of 40
-Asian women above the age of 50
CPT Code Information
82107
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
L3AFP | AFP-L3% and Total AFP, S | 96451-0 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
TAFP | Total AFP, S | 1834-1 |
L3 | %L3 | 42332-7 |
INT67 | Interpretation | 69048-7 |
Forms
If not ordering electronically, complete, print, and send 1 of the following forms with the specimen:
-Oncology Test Request (T729)